![Access to Global Capital: Investing in Growth](/sites/default/files/oembed_thumbnails/5dlp8k1ipY7SlAOVy8w35YsGud6ZnzwnigGP1bFuQC4.jpg)
Access to Global Capital: Investing in Growth
![A Conversation with William Clay Ford Jr.](/sites/default/files/oembed_thumbnails/qHH2uonbERf6OcdO_WjM2Qb6G9huBZ4eNupr0nHER5A.jpg)
A Conversation with William Clay Ford Jr.
![Leaning In or Pushed Out: Where Are the Senior Women in Business?](/sites/default/files/oembed_thumbnails/J3E0TIYIc9IgXe_EzLwxAXdf-yV_yGsBZbFAvTaG5Qs.jpg)
Leaning In or Pushed Out: Where Are the Senior Women in Business?
![Asia Rising: A New Competitive Landscape](/sites/default/files/oembed_thumbnails/A4MJ5KQwooq-zqsNIvYc89w6OJkuipRlZwX6zyPETNs.jpg)
Asia Rising: A New Competitive Landscape
![Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
![Request for Information on implementation of the Community Disaster Resilience Zones Act of 2022 – Federal Register Document Citation 88‐FR‐34171](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Request for Information on implementation of the Community Disaster Resilience Zones Act of 2022 – Federal Register Document Citation 88‐FR‐34171
![Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
![Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization – US House Energy & Commerce Committee](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)